SEC Contract Filing

Filing Date: 2018-08-10

Document Content:
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>eigr-ex104_259.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
eigr-ex104_259.htm
</title>
</head>
<!-- NG Converter v5.0.18157.137 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECOND AMENDMENT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LOAN AND SECURITY AGREEMENT</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIS <font style="font-weight:bold;">SECOND AMENDMENT </font>to Loan and Security Agreement (this &#8220;<font style="font-weight:bold;">Amendment</font>&#8221;) is entered into as of May 11, 2018, by and between <font style="font-weight:bold;">OXFORD FINANCE LLC</font>, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (&#8220;<font style="font-weight:bold;">Oxford</font>&#8221;), as collateral agent (in such capacity, &#8220;<font style="font-weight:bold;">Collateral Agent</font>&#8221;), the Lenders listed on <font style="text-decoration:underline;">Schedule 1.1</font> of the Loan Agreement (as defined below) or otherwise party thereto from time to time including Oxford in its capacity as a Lender (each a &#8220;<font style="font-weight:bold;">Lender</font>&#8221; and collectively, the &#8220;<font style="font-weight:bold;">Lenders</font>&#8221;), and EIGER BIOPHARMACEUTICALS, INC., a Delaware corporation (&#8220;<font style="font-weight:bold;">Parent</font>&#8221;), EB Pharma, LLC, a Delaware limited liability company (&#8220;<font style="font-weight:bold;">EB Pharma</font>&#8221;) and EBPI Merger, Inc., a Delaware corporation (&#8220;<font style="font-weight:bold;">EBPI</font>&#8221;), each with offices located at 2155 Park Blvd., Palo Alto, CA 94306 (Parent, EB Pharma and EBPI, individually and collectively, jointly and severally, &#8220;<font style="font-weight:bold;">Borrower</font>&#8221;).</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">R<font style="font-size:8pt;font-variant: small-caps;">ECITALS</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.<font style="margin-left:36pt;"></font><font style="font-weight:normal;">Collateral Agent, Lenders and Borrower have entered into that certain Loan and Security Agreement dated as of December 30, 2016 (as amended from time to time, the &#8220;</font>Loan Agreement<font style="font-weight:normal;">&#8221;).</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.<font style="margin-left:36pt;"></font><font style="font-weight:normal;">Lenders have extended credit to Borrower for the purposes permitted in the Loan Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">C.<font style="margin-left:36pt;"></font><font style="font-weight:normal;">Borrower has requested that Collateral Agent and Lenders (i) extend additional credit to Borrower and (ii) make certain other revisions to the Loan Agreement as more fully set forth herein.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">D.<font style="margin-left:36pt;"></font><font style="font-weight:normal;">Collateral Agent and Lenders have agreed to extend additional credit to Borrower and to amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A<font style="font-size:8pt;">GREEMENT</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N<font style="font-family:Times New Roman Bold;font-variant: small-caps;">ow</font>, T<font style="font-family:Times New Roman Bold;font-variant: small-caps;">herefore</font>, <font style="font-weight:normal;">in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:bold;font-size:1